Posted inBiologic Drugs BioTech Medicines
Unprecedented momentum in the US biologics market
A wave of biosimilar approvals, aggressive pricing strategies, and a regulatory sea change are setting the stage for unprecedented momentum in the US biologics market, with 2025 already proving to…
